You are currently on the new version of our website. Access the old version .

Livers, Volume 3, Issue 4

December 2023 - 11 articles

Cover Story: Acetaminophen (APAP) is a widely used drug, but overdose can cause severe acute liver injury. The first reports of APAP hepatotoxicity in humans were published in 1966, shortly after the development of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) as the first biomarkers of liver injury as opposed to liver function. Thus, the field of liver injury biomarkers has evolved alongside the growth in APAP hepatotoxicity incidence. Numerous biomarkers have been proposed for use in the management of APAP overdose patients in the intervening years. Here, we comprehensively review the development of these markers from the 1960s to the present day and briefly discuss possible future directions. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (11)

  • Article
  • Open Access
1 Citations
2,503 Views
12 Pages

Exosome Shedding Is Concordant with Objective Treatment Response Rate and Stratifies Time to Progression in Treatment Naïve, Non-Resectable Hepatocellular Carcinoma

  • Kelley G. Núñez,
  • Dorota Wyczechowska,
  • Mina Hibino,
  • Tyler Sandow,
  • Juan Gimenez,
  • Ali R. Koksal,
  • Yucel Aydin,
  • Srikanta Dash,
  • Ari J. Cohen and
  • Paul T. Thevenot

8 December 2023

Translational strategies to characterize and monitor extracellular vesicles such as exosome (EX) shedding and the clinical impact of this data within hepatocellular carcinoma (HCC) remains unclear. In this study, EX shedding was assessed in early-sta...

  • Review
  • Open Access
4 Citations
4,426 Views
18 Pages

The Role of Normothermic Machine Perfusion in Extended Criteria Donor Grafts: A New Direction in Liver Graft Assessment and Preservation

  • Dima Malkawi,
  • Kush Savsani,
  • Anjelica Alfonso,
  • Seung Duk Lee,
  • Nicholas James,
  • Devanand Sarkar,
  • Daisuke Imai,
  • Aamir Khan,
  • Amit Sharma and
  • Vinay Kumaran
  • + 3 authors

1 December 2023

Despite improvements in short-term and long-term outcomes of liver transplant patients, the discrepancy between the number of available livers and transplant candidates continues to increase. The use of expanded criteria donors is one strategy that c...

  • Review
  • Open Access
7 Citations
9,573 Views
22 Pages

Crosstalk between Lipids and Non-Alcoholic Fatty Liver Disease

  • Divyavani Gowda,
  • Chandra Shekhar,
  • Siddabasave Gowda B. Gowda,
  • Yifan Chen and
  • Shu-Ping Hui

23 November 2023

Non-alcoholic fatty liver disease (NAFLD), a complex liver disorder that can result in non-alcoholic steatohepatitis, cirrhosis, and liver cancer, is the accumulation of fat in the liver seen in people due to metabolic dysfunction. The pathophysiolog...

  • Article
  • Open Access
2,281 Views
13 Pages

16 November 2023

Laparoscopic posterosuperior liver segment resection is considered technically challenging. This is a retrospective single-center single-surgeon study. The aim of the present study is to investigate the short-term outcomes in a single institution bet...

  • Article
  • Open Access
2 Citations
5,817 Views
17 Pages

The Computed Sinusoid

  • Matteo Boninsegna,
  • Peter A. G. McCourt and
  • Christopher Florian Holte

11 November 2023

Hepatic sinusoids are lined with thin endothelial cells with transcellular pores, termed fenestrations. These fenestrations are open channels that connect the sinusoidal lumen to the underlying Space of Disse (SoD) and the hepatocytes of the liver pa...

  • Review
  • Open Access
9 Citations
12,377 Views
20 Pages

Advancements in Understanding and Treating NAFLD: A Comprehensive Review of Metabolic-Associated Fatty Liver Disease and Emerging Therapies

  • Jacob Beiriger,
  • Kashyap Chauhan,
  • Adnan Khan,
  • Taha Shahzad,
  • Natalia Salinas Parra,
  • Peter Zhang,
  • Sarah Chen,
  • Anh Nguyen,
  • Brian Yan and
  • John Bruckbauer
  • + 1 author

7 November 2023

This paper provides a comprehensive review of the current understanding of non-alcoholic fatty liver disease (NAFLD) and its progression to non-alcoholic steatohepatitis (NASH), focusing on key factors influencing its pathogenesis and emerging therap...

  • Review
  • Open Access
16 Citations
22,364 Views
19 Pages

Hidden Dangers: Herbal and Dietary Supplement Induced Hepatotoxicity

  • Jonathan Kwong-Shing Lin and
  • Shannan R. Tujios

31 October 2023

Herbal and dietary supplements represent a multi-billion-dollar industry reportedly used by over half of American adults. However, these products are not regulated by the Federal Drug Agency and contain a wide range of contaminants, leading to over 5...

  • Review
  • Open Access
9 Citations
11,508 Views
21 Pages

28 October 2023

Metabolic dysfunction associated fatty liver disease (MAFLD) has been recently recognized as a new global chronic liver disease entity with non-alcoholic fatty liver disease (NAFLD) associated with overweight/obesity or type 2 diabetes mellitus (T2DM...

  • Feature Paper
  • Review
  • Open Access
9 Citations
13,230 Views
28 Pages

27 October 2023

Acetaminophen (APAP) is a widely used drug, but overdose can cause severe acute liver injury. The first reports of APAP hepatotoxicity in humans were published in 1966, shortly after the development of alanine aminotransferase (ALT) and aspartate ami...

  • Communication
  • Open Access
1 Citations
2,714 Views
7 Pages

Pemafibrate Improves Alanine Aminotransferase Levels Independently of Its Lipid-Lowering Effect

  • Azuma Watanabe,
  • Ryoko Horigome,
  • Yumiko Nakatsuka and
  • Shuji Terai

23 October 2023

Aim: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. Pemafibrate, a selective peroxisome-proliferator-activated receptor α modulator (SPPARMα), has been reported to ameliorate liver function am...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Livers - ISSN 2673-4389